glp 1 drugs and gallstones Understanding the Side Effects of GLP-1 Medications What are the risks of
Description
is a co-inventor on intellectual property owned by Indiana University and licensed to Novo Nordisk
Lixisenatide The FDA approved lixisenatide, marketed as Adlyxin, in 2016 for Type 2 diabetes
doi:10.2337/db19-54-OR 44
In the brain, GLP-1 treatment has a preventive effect on the progression of Alzheimers disease pathology in rats (Iwai et al., 2014
Jia IT et al
In animal studies by Burmeister et al
